Royal Philips, Amsterdam, the Netherlands, has launched a remote monitoring and defibrillator solution (Tempus ALS) for pre-hospital settings in the United States. The solution is a complete end-to-end system that combines innovative hardware and advanced software to expand the pre-hospital scope of care for first responders. The professional defibrillator (Tempus LS-Manual) is the final element of the overall solution to receive 510(k) clearance from the U.S. FDA and is now available for sale in the U.S. market. 

As a unique modular platform, the remote monitoring and defibrillator solution (Tempus ALS) consists of a remote portable vital signs patient monitor (Tempus Pro), and remote professional defibrillator (Tempus LS-Manual). While the monitor and defibrillator can be used separately, the devices also connect wirelessly to share data and transfer vitals, waveforms, and images into Philips’ web-based software platform (IntelliSpace Corsium).

The software platform provides robust, real-time transfer of clinical data and events, interactive ECG measurement, two-way communication, and more to enable rapid clinical and transport decision support and seamless electronic patient care recording (ePCR) integration outside the hospital in emergency settings. 

“In emergency situations, where seconds count, having access to advanced patient data collection and sharing and real-time secure data streaming can help inform confident treatment and transport decisions outside the hospital,” says Arman Voskerchyan, general manager of therapeutic care at Philips. “The integrated remote monitoring and defibrillator solution combined with our web-based software platform will help front line responders provide emergency care, diagnosis, and treatment—including defibrillation therapy, data management, and clinical and operational efficiency features—in a fully integrated solution.”

Featured image: Philips Tempus ALS remote monitor and defibrillator solution (credit: Royal Philips)